Vasen HF - Search Results

1

Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.

Heemskerk-Gerritsen BA, Rookus MA, Aalfs CM, Ausems MG, Collée JM, Jansen L, Kets CM, Keymeulen KB, Koppert LB, Meijers-Heijboer HE, Mooij TM, Tollenaar RA, Vasen HF; HEBON; Hooning MJ, Seynaeve C. Heemskerk-Gerritsen BA, et al. Among authors: vasen hf. Int J Cancer. 2015 Feb 1;136(3):668-77. doi: 10.1002/ijc.29032. Epub 2014 Jul 8. Int J Cancer. 2015. PMID: 24947112

2

The outcome of endometrial carcinoma surveillance by ultrasound scan in women at risk of hereditary nonpolyposis colorectal carcinoma and familial colorectal carcinoma.

Dove-Edwin I, Boks D, Goff S, Kenter GG, Carpenter R, Vasen HF, Thomas HJ. Dove-Edwin I, et al. Among authors: vasen hf. Cancer. 2002 Mar 15;94(6):1708-12. doi: 10.1002/cncr.10380. Cancer. 2002. PMID: 11920532 Free article.

3

Correspondence re: A. Müller et al., Exclusion of breast cancer as an integral tumor of hereditary nonpolyposis colorectal cancer. Cancer Res., 62: 1014-1019, 2002.

de Leeuw WJ, van Puijenbroek M, Tollenaar RA, Cornelisse CJ, Vasen HF, Morreau H. de Leeuw WJ, et al. Among authors: vasen hf. Cancer Res. 2003 Mar 1;63(5):1148-9. Cancer Res. 2003. PMID: 12615735 No abstract available.

4

The CHEK2*1100delC variant acts as a breast cancer risk modifier in non-BRCA1/BRCA2 multiple-case families.

Oldenburg RA, Kroeze-Jansema K, Kraan J, Morreau H, Klijn JG, Hoogerbrugge N, Ligtenberg MJ, van Asperen CJ, Vasen HF, Meijers C, Meijers-Heijboer H, de Bock TH, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: vasen hf. Cancer Res. 2003 Dec 1;63(23):8153-7. Cancer Res. 2003. PMID: 14678969

5

Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer.

de Jong AE, van Puijenbroek M, Hendriks Y, Tops C, Wijnen J, Ausems MG, Meijers-Heijboer H, Wagner A, van Os TA, Bröcker-Vriends AH, Vasen HF, Morreau H. de Jong AE, et al. Among authors: vasen hf. Clin Cancer Res. 2004 Feb 1;10(3):972-80. doi: 10.1158/1078-0432.ccr-0956-3. Clin Cancer Res. 2004. PMID: 14871975

6

Survival after adjuvant 5-FU treatment for stage III colon cancer in hereditary nonpolyposis colorectal cancer.

de Vos tot Nederveen Cappel WH, Meulenbeld HJ, Kleibeuker JH, Nagengast FM, Menko FH, Griffioen G, Cats A, Morreau H, Gelderblom H, Vasen HF. de Vos tot Nederveen Cappel WH, et al. Among authors: vasen hf. Int J Cancer. 2004 Apr 10;109(3):468-71. doi: 10.1002/ijc.11712. Int J Cancer. 2004. PMID: 14961589

7

A prospective study on predictive factors linked to the presence of BRCA1 and BRCA2 mutations in breast cancer patients.

Wárlám-Rodenhuis CC, Koot VC, van der Luijt RB, Vasen HF, Ausems MG. Wárlám-Rodenhuis CC, et al. Among authors: vasen hf. Eur J Cancer. 2005 Jul;41(10):1409-15. doi: 10.1016/j.ejca.2005.02.030. Eur J Cancer. 2005. PMID: 15955690

8

Long term follow-up of HNPCC gene mutation carriers: compliance with screening and satisfaction with counseling and screening procedures.

Wagner A, van Kessel I, Kriege MG, Tops CM, Wijnen JT, Vasen HF, van der Meer CA, van Oostrom II, Meijers-Heijboer H. Wagner A, et al. Among authors: vasen hf. Fam Cancer. 2005;4(4):295-300. doi: 10.1007/s10689-005-0658-9. Fam Cancer. 2005. PMID: 16341806

9

Decrease in mortality in Lynch syndrome families because of surveillance.

de Jong AE, Hendriks YM, Kleibeuker JH, de Boer SY, Cats A, Griffioen G, Nagengast FM, Nelis FG, Rookus MA, Vasen HF. de Jong AE, et al. Among authors: vasen hf. Gastroenterology. 2006 Mar;130(3):665-71. doi: 10.1053/j.gastro.2005.11.032. Gastroenterology. 2006. PMID: 16530507

10

Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping.

Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I, Vasen HF, Cleton-Jansen AM, Kraan J, Houwing-Duistermaat JJ, Morreau H, Cornelisse CJ, Devilee P. Oldenburg RA, et al. Among authors: vasen hf. Clin Cancer Res. 2006 Mar 15;12(6):1693-700. doi: 10.1158/1078-0432.CCR-05-2230. Clin Cancer Res. 2006. PMID: 16551851

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

386 results

Search Page

Filters